This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fang Cheng and Pharmaceutical Crystal-Form Innovation.
Introduction
Fang Cheng is an inventor based in Jinan, China, whose patent work concerns the crystal forms of entrectinib, a pharmaceutical compound. His listed patent is associated with Qilu Pharmaceutical Co., Ltd.
Latest Patents
Cheng is credited with 1 patent, titled “Crystal Form of Entrectinib and Preparation Method Therefor.” The patent describes crystal forms A and B of entrectinib and methods for preparing them. According to the supplied description, these forms offer improved solubility and chemical and crystal-form stability compared with existing forms. They are also described as having low static electricity, good flowability, and suitability for large-scale preparation and pharmaceutical formulation.
Career Highlights
Cheng’s listed invention focuses on pharmaceutical solid forms and their preparation. The patent highlights properties intended to support formulation development and scalable production.
Collaborations
The patent information names Chuanxin Leng and Huicheng Wang as Cheng’s coworkers. The invention is associated with Qilu Pharmaceutical Co., Ltd.
Conclusion
Fang Cheng’s listed patent addresses the preparation and practical properties of entrectinib crystal forms, with an emphasis on stability, formulation suitability, and large-scale production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile